Clene Reports Reduction in Biomarker Plasma Neurofilament Light (NfL) Levels and Improved ...
CNM-Au8 30mg treatment demonstrated significantly reduced plasma neurofilament light chain (NfL) levels at 76 weeks relative to placebo (18 months from randomization, p=0.023)60% decreased risk of long-term all-cause mortality (>18
Salt Lake City United States Benjamin Greenberg Jamesd Berry Seanm Healey Motor Neuron Disorder Division
Source: eagletribune.com